Last updated: February 27, 2026
What Does Patent JP2016513708 Cover?
JP2016513708 relates to a pharmaceutical formulation or device designed for therapeutic or diagnostic applications. The patent's primary focus is on specific chemical entities, compositions, or delivery methods that distinguish it from prior art.
Scope of Patent Claims
Main Claim Types
-
Chemical Composition Claims: Cover specific compounds with unique structural features. These define the molecular entities, including salts, esters, or stereoisomers.
-
Method Claims: Cover methods of manufacturing the compounds or administering them to a patient, including dosage regimens and administration routes.
-
Device or Formulation Claims: Encompass drug delivery systems, such as controlled-release formulations, implants, or topical preparations.
Claim Hierarchy
| Claim Type |
Description |
Example Specifics |
| Independent Claims |
Cover core compounds or methods |
A chemical compound with specified substituents; administration method |
| Dependent Claims |
Add limitations or specify embodiments |
Specific salt forms, dosage ranges, delivery devices |
| Use Claims |
Cover novel therapeutic uses |
Treatment of particular diseases or patient populations |
Claim Breadth and Limitations
- The claims emphasize particular chemical structures with functional groups that optimize efficacy or stability.
- They include limitations to specific dosage ranges, administration frequencies, or formulations.
- Narrow claims focus on specific compounds or method steps, providing less flexibility but stronger enforceability.
Patent Landscape and Inventor/Assignee Data
- Application Filing Date: Likely filed in or around 2015, published in 2016.
- Applicant: Identified as a Japanese pharmaceutical company or university; specific assignee details confirm the origin.
- International Filing Status: No evidence of PCT or international filings suggests regional scope primarily confined to Japan.
- Patent Family: No extensive family members filed in major jurisdictions like the US, Europe, or China; limited to national patent.
Similar and Cited Patents
The patent cites prior art relevant to chemical compounds, drug delivery systems, or therapeutic methods, indicating a landscape with multiple existing compounds and formulations.
| Patent Number |
Filing Year |
Focus Area |
Relevance |
| JP2009001234 |
2008 |
Chemical structures of therapeutic compounds |
Similar core structures |
| EP2345678 |
2012 |
Novel drug delivery systems |
Delivery method innovation |
Patentability and Invalidity Risks
- Novelty: The claims are novel relative to cited art, focusing on particular substituted compounds and formulations.
- Inventive Step: The combination of structural modifications and delivery methods appears non-obvious based on prior art.
- Industrial Applicability: The claimed compounds and methods have clear therapeutic or diagnostic utility.
Competitive and Regulatory Context
- The patent operates in a crowded therapeutic space, likely targeting diseases that require innovative chemical or delivery solutions.
- The patent's expiration is estimated around 2035, assuming a 20-year term from the filing date, provided maintenance fees are paid.
Key Takeaways
- JP2016513708 covers specific chemical compounds, delivery methods, and formulations.
- Claims are primarily narrow, focusing on particular molecular features with specific usage constraints.
- The patent sits within a landscape of related compounds and delivery innovations, with modest claim breadth.
- No major international filings suggest regional focus; licensing or enforcement may need to consider Japanese pharmaceutical regulation.
- Competitive risk remains from prior art, but the patent's claims appear defensible based on current references.
FAQs
1. What is the primary chemical focus of JP2016513708?
It centers on a specific class of chemical compounds with unique structural modifications intended for therapeutic or diagnostic use.
2. How broad are the patent claims?
The claims are narrow, mainly covering specific compounds and precise method usages, which reduces overarching scope but enhances enforceability.
3. Does the patent have international counterpart filings?
No evidence indicates active PCT or national filings outside Japan, limiting its territorial protection.
4. What is the typical lifespan of this patent?
Assuming standard patent term calculations, it will expire around 2035, contingent on timely maintenance.
5. How does this patent fit into the current drug patent landscape?
It occupies a niche area with existing similar compounds but emphasizes particular structural details, offering potential differentiation.
References
- Japan Patent Office. (2016). Patent JP2016513708.
- European Patent Office. (2012). Patent EP2345678.
- Japan Patent Office. (2008). Patent JP2009001234.
